New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
08:07 EDTGHDXGenomic Health announces positive results of Oncotype DX in colon cancer
Genomic Health announced results from three studies of the Oncotype DX Colon Cancer test at the 2013 Gastrointestinal Cancers Symposium, including new data demonstrating that Recurrence Score results changed treatment recommendations in 45% of the enrolled stage II colon cancer patients. Presentations also include positive findings from a second health economics analysis suggesting that use of the test may result in a significant reduction in direct medical costs and improve patient well-being.
News For GHDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 20, 2015
08:04 EDTGHDXGenomic Health reports positive data on positive impact of Oncotype DX test
Genomic Health announced that 11 studies were presented at the 14th St. Gallen International Breast Cancer Conference, including positive results from a real-life observational study in Ireland.1 That study demonstrated that use of the Oncotype DX test in early-stage breast cancer led to a 58 percent net reduction in chemotherapy use, resulting in net cost savings of nearly EUR 800,000, or approximately EUR 1,200 in cost savings per patient.
March 13, 2015
09:49 EDTGHDXUBS life science tools/diagnostics analyst has analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use